BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 18431461)

  • 1. HMGB1: endogenous danger signaling.
    Klune JR; Dhupar R; Cardinal J; Billiar TR; Tsung A
    Mol Med; 2008; 14(7-8):476-84. PubMed ID: 18431461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1.
    Harris HE; Raucci A
    EMBO Rep; 2006 Aug; 7(8):774-8. PubMed ID: 16858429
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of high mobility group box 1 in innate immunity.
    Lee SA; Kwak MS; Kim S; Shin JS
    Yonsei Med J; 2014 Sep; 55(5):1165-76. PubMed ID: 25048472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.
    Yang H; Wang H; Chavan SS; Andersson U
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S6-S12. PubMed ID: 26605648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility group box-1 in sterile inflammation.
    Tsung A; Tohme S; Billiar TR
    J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury.
    Deng C; Zhao L; Yang Z; Shang JJ; Wang CY; Shen MZ; Jiang S; Li T; Di WC; Chen Y; Li H; Cheng YD; Yang Y
    Acta Pharmacol Sin; 2022 Mar; 43(3):520-528. PubMed ID: 34040166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus.
    Yu SL; Wong CK; Tam LS
    Expert Rev Clin Immunol; 2013 Aug; 9(8):739-49. PubMed ID: 23971752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming.
    Frank MG; Weber MD; Watkins LR; Maier SF
    Brain Behav Immun; 2015 Aug; 48():1-7. PubMed ID: 25816800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
    DeMarco RA; Fink MP; Lotze MT
    Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
    Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
    Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immune Tolerance Role of the HMGB1-RAGE Axis.
    Watanabe H; Son M
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.
    Pisetsky DS; Erlandsson-Harris H; Andersson U
    Arthritis Res Ther; 2008; 10(3):209. PubMed ID: 18598385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis.
    Foell D; Wittkowski H; Roth J
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):382-90. PubMed ID: 17599072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is HMGB1 an osteocyte alarmin?
    Bidwell JP; Yang J; Robling AG
    J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration.
    Yamashiro K; Ideguchi H; Aoyagi H; Yoshihara-Hirata C; Hirai A; Suzuki-Kyoshima R; Zhang Y; Wake H; Nishibori M; Yamamoto T; Takashiba S
    Front Immunol; 2020; 11():1461. PubMed ID: 32760399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.
    Andersson U; Yang H; Harris H
    Semin Immunol; 2018 Aug; 38():40-48. PubMed ID: 29530410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.